## OXY: Occidental Petroleum Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_10 -1.2% below STRENGTH zone (3.0-6.0%); PEG 2.36 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.24)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Thrivent Financial for Lutherans Purchases 43,814 Shares of Occidental Petroleum Corporation $OXY**
- Source: MarketBeat | 20251222T100942 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans significantly increased its stake in Occidental Petroleum Corporation by 130.1% in the second quarter, acquiring 43,814 additional shares and bringing its total holdings to 77,488 shares valued at approximately $3.26 million. Other institutional investors like Vanguard Group Inc. and State Street Corp also boosted their positions. Occidental Petroleum (NYSE:OXY) reported quarterly earnings that beat estimates and declared a $0.24 per share quarterly dividend, maintaining a "Hold" rating from analysts with an average price target of $49.95.

**2. Assenagon Asset Management S.A. Sells 93,564 Shares of Occidental Petroleum Corporation $OXY**
- Source: MarketBeat | 20251222T082444 | Neutral | Relevance: 100%
- Assenagon Asset Management S.A. significantly reduced its stake in Occidental Petroleum Corporation by selling 93,564 shares, decreasing its holdings by 43.7% to 120,538 shares valued at $5.695 million. This divestment occurred as Occidental declared a quarterly dividend of $0.24, and analysts maintain a consensus "Hold" rating for the stock. Despite beating EPS estimates, the company's revenue saw a 6.1% year-over-year decline.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $43 | $45 | -4% |
| 2025-12-11 | B of A Securiti | $44 | $45 | -2% |
| 2025-12-08 | JP Morgan | $44 | $51 | -14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Neutral |
| 2025-12-11 | B of A Securiti | main | Neutral |
| 2025-12-08 | JP Morgan | down | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.19M) |
| Sells | 1 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Berkshire Hathaway, : 26.9% (0.0%)
- Vanguard Group Inc: 9.1% (+0.8%)
- Dodge & Cox Inc.: 8.1% (-0.5%)
- Blackrock Inc.: 5.0% (+3.4%)
- State Street Corpora: 3.9% (-0.9%)

### Key Risks

1. Long-term trend broken: trading 7.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.36 elevated, pricing in significant growth expectations. Balance sheet: $1.0B free cash flow. Revenue declining -18% YoY, concerning. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $39.7B |
| Beta | 0.39 |
| 52W Range | $34.78 - $53.20 |
| Short Interest | 5.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.36 |
| Forward P/E | 25.6 |
| Current P/E | 17.9 |
| YoY Growth | -30.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -4.3% to -1.2% (+3.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.2pp (needs >3.0% for momentum thesis). Below SMA200 (0.93x), long-term trend not supportive. RSI neutral at 44. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.22% (CS: 30) | Neutral |
| RSI_14 | 44.2 | Neutral |
| MACD Histogram | -0.16 | Bearish |
| vs SMA20 | 0.977x | Below |
| vs SMA50 | 0.973x | Below |
| vs SMA200 | 0.928x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.26
- **Stop Loss:** $38.24 (5.0% risk)
- **Target:** $42.28 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 297
- **Position Value:** $11,957.22
- **Portfolio %:** 11.96%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-17 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.50 | $0.64 | +26.8% |
| 2025Q2 | $0.31 | $0.39 | +24.8% |
| 2025Q1 | $0.76 | $0.87 | +14.0% |
| 2024Q4 | $0.67 | $0.80 | +19.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*